Mike Davies

Company: Carocell Bio

Job title: Chief Executive Officer

Seminars:

Curative vs. Chronic Treatment in Atopic Dermatitis: Navigating Commercial & Clinical Implications 1:30 pm

Review early safety profiles of therapeutic peptides in Atopic Dermatitis, examining their potential for targeted disease modification  Compare emerging pathways targeting disease modification against established symptomatic treatments – evaluating clinical and commercial trade-offs  Discuss how one-time curative interventions could disrupt current reimbursement models and challenge ROI metrics in dermatology Read more

day: Day One

️Panel Discussion: Searching for the ‘Crystal Ball of Dermatology’: Disease Modification 2:00 pm

What progress has the industry made in shifting from symptom management to truly modifying disease pathways in conditions like Atopic Dermatitis, Hidradenitis Suppurativa, Vitiligo, and Pruritis?  What are the key biological targets and mechanisms that show the most promise for delaying, slowing, or reversing disease progression in immunodermatology?  What lessons can be learned from other…Read more

day: Day One